PharmStars’ Fall 2026 cohort will focus on startups with “Digital Innovations in Immunology.” We welcome applications from startups with any type of digital product or prototype relating to immune-mediated diseases or immune-based interventions.
All digital health startups with an interest in partnering with pharma are welcome to apply. For our first cohort, priority will be given to startups with innovative digital health solutions that enhance and improve any aspect of clinical trials. Additional details can be found here.